Max-Delbrück-Centrum für Molekulare Medizin Company Profile

02:04 EDT 18th June 2018 | BioPortfolio

Berlin-Buch has a long tradition as a medical research center: as early as the start of the 20th century there was an important clinical center there with a number of associated units that at times provided over 5000 beds.

Between 1928 and 1930, the Kaiser Wilhelm Society established an Institute of Brain Research on what is now the present Berlin-Buch Campus. At that time, the institute was the largest and most modern of its kind in the world. In charge of the institute and its associated clinics was Oskar Vogt who, with his wife Cécile, were two of the pioneers in the field of modern brain research. Vogt managed to get the Russian geneticist, Nikolai Wladimirovich Timoféeff-Ressovsky involved in setting up a Department of Experimental Genetics at his institute. During the Nazi period, the brains from victims who had been killed as part of the Nazi euthanasia program were used for research purposes at the Kaiser Wilhelm Institute of Brain Research. There is a memorial on the campus to remind people of this.

In 1947, the German Academy of Sciences in Berlin set up the Institute of Medicine and Biology in the former Institute of the Kaiser Wilhelm Society. This grew into an internationally celebrated center for cancer and cardiovascular research in which basic and clinical research were closely integrated. In 1972, the Institutes of the GDR Academy of Sciences, which had been established after 1947 from the Institute of Medicine and Biology, were formed into three central institutes for cancer research, cardiovascular research and molecular biology. After the reunification of East and West Germany, these three institutes became the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch in 1992. The two research clinics that had belonged to the central institutes became incorporated into the Charité of the Humboldt University of Berlin.


Berlin-BuchRobert-Rössle-Str. 10


Phone: 49 - 30/9406-0
Fax: 49 - 30/949 4161

News Articles [24 Associated News Articles listed on BioPortfolio]

Novo Nordisk, BB Biotech und Roche: Keine bittere (Dividenden-)Pille

Die stetig steigende Lebenserwartung von Menschen in Industrienationen beruht zum Großteil auf Fortschritten in der Medizin und Pharmazie. Dementsprechend groß ist das Potenzial, das viele Biotech-....

Co.don: Spezialist im Bereich Personalisierte Medizin - Aktie vor Aufholjagd?

Nach den zahlreichen starken News im vergangenen Jahr und einer Rallye bis in den Bereich von 13 Euro ist es in den vergangenen Monaten etwas ruhiger geworden um den Knorpel-Spezialisten Co.don. De...

Meet & Match: Bioprozesse – Simulieren | Überwachen | Steuern

Am 12. September 2017 veranstaltet die BIOPRO Baden-Württemberg gemeinsam mit der Fraunhofer Projektgruppe für Automatisierung in der Medizin und Biotechnologie (PAMB) in Mannheim ein Meet & Match z...

Developmental scars

(Max Delbrück Center for Molecular Medicine in the Helmholtz Association) The MDC researcher Jan Philipp Junker and his team have used CRISPR-Cas9 genome editing to pioneer a technique capable of det...

Nytt centrum för Huntingtons sjukdom

Sahlgrenska satsar på en gemensam resurs för alla som berörs av Huntingtons sjukdom.

GSK, RB no longer in running for Pfizer Consumer business

Keeping the excitement under control

(Max Delbrück Center for Molecular Medicine in the Helmholtz Association) James Poulet's lab at the MDC uses advanced techniques to monitor the activity of networks of single sensory neurons in the b...

Enerkem dokonuje przełomu, wytwarzając nowe wysokooktanowe biopaliwo

Posiadana przez Centrum Innowacyjności Enerkem, zlokalizowane w Westburyw prowincji Quebec, specjalistyczna wiedza z zakresu inżynierii chemicznej umożliwiła spółce opracowanie procesu, w któ...

Drugs and Medications [0 Results]


PubMed Articles [98 Associated PubMed Articles listed on BioPortfolio]

Developmental toxicity of flucytosine following administration to pregnant rats at a specific time point of organogenesis.

To investigate the abnormalities that are specific to administration of flucytosine at one time point during embryonic organogenesis, flucytosine was administered orally to pregnant SD rats in a singl...

Complete Reversal of Diffusion Restriction after Treatment of Traumatic Carotid-Cavernous Fistula.

A 15-year-old man presented with stupor following a motorcycle traffic accident. The patient was diagnosed with a traumatic left carotid cavernous fistula (CCF) with pseudoaneurysm of the left interna...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Role of Centrum® Silver® in Improving Micronutrient Status in Older Men

Older adults are susceptible to vitamin and mineral deficiencies for a variety of reasons and have an increased demand for many of these micronutrients. Multivitamin/multimineral supplemen...

Diurnal Variations of Brain Metabolite Concentrations in 1H-MRS

Proton Magnetic Resonance Spectroscopy (1H-MRS) is a magnetic resonance imaging (MRI) technique. It allows the quantification of cerebral metabolite concentrations. Currently, MRS-1H is us...

Multivitamins do Not Improve Radiation Therapy Related Fatigue

Multivitamins (MVi) are broadly used by cancer patients to improve overall health and energy. Fatigue is a common symptom in cancer patients including those receiving radiation therapy. W...

The Role of Antioxidant Supplementation in Keratoconus Patients

Keratoconus is the most common primary cornea ectasia, where the cornea undergoes structural changes, leading to loss of tissue integrity and vision loss. The prevalence of Keratoconus is ...

Influence of Preoperative Anxiety on Shivering During Elective Caesarean Section Under Spinal Anaesthesia

Background Shivering occurs in circa 50 percent of cases during caesarean section under spinal anesthesia. The phenomenon's reasons and its mechanism are unclear, and while it does not end...

Companies [11 Associated Companies listed on BioPortfolio]

Max-Delbrück-Centrum für Molekulare Medizin

Berlin-Buch has a long tradition as a medical research center: as early as the start of the 20th century there was an important clinical center there with a number of associated units that at times pr...

VU medisch centrum




Zentralbibliothek für Medizin


Pfizer Consumer Healthcare

Centrum Silver

More Information about "Max-Delbrück-Centrum für Molekulare Medizin" on BioPortfolio

We have published hundreds of Max-Delbrück-Centrum für Molekulare Medizin news stories on BioPortfolio along with dozens of Max-Delbrück-Centrum für Molekulare Medizin Clinical Trials and PubMed Articles about Max-Delbrück-Centrum für Molekulare Medizin for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Max-Delbrück-Centrum für Molekulare Medizin Companies in our database. You can also find out about relevant Max-Delbrück-Centrum für Molekulare Medizin Drugs and Medications on this site too.

Quick Search


Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record